ContractRoyalty Purchase Agreement • November 7th, 2018 • Agenus Inc • Biological products, (no disgnostic substances) • New York
[********] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
AMENDMENT NO. 1 TO CONSULTING AGREEMENTConsulting Agreement • November 7th, 2018 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This AMENDMENT NO. 1 TO CONSULTING AGREEMENT (this “Amendment”), effective as of July 1, 2018 (the “Amendment Effective Date”), is by and between Agenus Inc., a Delaware corporation having an address at 149 Fifth Avenue, Suite 500, New York, NY 10010 (the “Company”), and Dr. Robert Stein, an individual currently residing at 7 Peter Cooper Rd., Apt 10-B, New York, NY 10010 (the “Consultant”) (each a “Party” and together the “Parties”). Capitalized terms used in this Amendment and not otherwise defined herein shall have those meanings attributed to them in the Agreement (as defined below).
CONSULTING AGREEMENTConsulting Agreement • November 7th, 2018 • Agenus Inc • Biological products, (no disgnostic substances) • Massachusetts
This Consulting Agreement (the “Agreement”), effective as of July 12, 2018 (the “Effective Date”), is made by and between Agenus Inc., a Delaware corporation having an address at 3 Forbes Road, Lexington, MA 02421 (“Agenus”), and Karen H. Valentine, an individual having an address at 15 Sarah Way, Concord, MA 01742 (the “Consultant”) (each a “Party” and collectively the “Parties”).
CONSULTING AGREEMENTConsulting Agreement • November 7th, 2018 • Agenus Inc • Biological products, (no disgnostic substances) • Delaware
This Consulting Agreement (the “Agreement”), effective as of July 1, 2018 (the “Effective Date”), is made between AgenTus Therapeutics, Inc., a Delaware corporation, having an address at 3 Forbes Road, Lexington, MA 02421 (“AgenTus”), and Dr. Robert Stein, an individual currently residing at 7 Peter Cooper Rd., Apt 10-B, New York, NY 10010 (the “Consultant”) (each a “Party” and collectively the “Parties”).
